Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
France: people who inject drugs often given cheaper, less effective, hepatitis C medication

People living with HIV and hepatitis C (HCV) who have a history of injecting drug use are being offered less effective, but cheaper, HCV medication than other people with HIV/HCV co-infections, new research from France finds.

Published
17 July 2018
From
AVERT
Hepatitis C vaccine could dramatically reduce transmission in people who inject drugs

Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users. A study published in Science Translational Medicine shows that if a hepatitis C vaccine were successfully developed, it would dramatically reduce transmission of hepatitis C among drug users -- even though it's unlikely such a vaccine would provide complete immunity.

Published
12 July 2018
From
Eurekalert Inf Dis
Using hepatitis C-infected donor kidneys could reduce time on dialysis for transplant patients with HCV

Transplanting hepatitis C-infected dialysis patients with HCV-positive donor organs and then treating the infection later is more effective, cheaper and shortens organ wait time.

Published
10 July 2018
From
Eurekalert Inf Dis
State Prisons Fail To Offer Cure To 144000 Inmates With Deadly Hepatitis C

State prisons across the U.S. are failing to treat at least 144,000 inmates who have hepatitis C, a curable but potentially fatal liver disease, according to a recent survey and subsequent interviews of state corrections departments.

Published
09 July 2018
From
Kaiser Health News
Cost-effective universal screening for hepatitis C in France

The modeling results show that universal screening is associated with better life expectancy adjusted for quality of life than other strategies. Universal screening is cost-effective if the patients tested for HCV infection are treated rapidly after diagnosis.

Published
02 July 2018
From
EurekAlert (press release)
$20 blood test could help diagnose hepatitis B patients across Africa

Researchers have developed an accurate diagnostic score that consists of inexpensive blood tests to identify patients who require immediate treatment against the deadly hepatitis B virus -- which can lead to liver damage or cancer.

Published
02 July 2018
From
Science Daily
Coinfection Connection

Curing hepatitis C is a priority for people also living with HIV.

Published
27 June 2018
From
POZ
Another Adverse Effect of the Opioid Epidemic: Hepatitis C Infections

Amid the ongoing opioid epidemic, hepatitis C virus (HCV) infection should be at the forefront of health care providers’ minds. Although HCV has been widely viewed as predominantly affecting baby boomers—those born between 1945 and 1965—a younger generation is experiencing increased incidence of infection.

Published
20 June 2018
From
Contagion Live
MSF challenges Gilead's undeserved patent in China on lifesaving hepatitis C medicine

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) filed a legal patent challenge today at China’s State Intellectual Property Office (SIPO), requesting the invalidation of the patent it granted to US pharmaceutical corporation Gilead Sciences in 2012 for the oral hepatitis C medicine velpatasvir. This unmerited patent means this lifesaving medicine could remain priced out of reach for several more years, leaving millions of people to unnecessarily go without in China and abroad.

Published
20 June 2018
From
MSF press release
Just 12 countries worldwide on track to eliminate hepatitis C infection by 2030

Since the last global update in 2017, Italy, Spain, Switzerland, the UK and Mongolia have all been added to the list, thanks to the number of patients they treated in 2017, plus the lifting of treatment restrictions to include all patients with hepatitis C regardless of their degree of liver damage. These countries join the others already on track to eliminate by 2030: Australia, Egypt, France, Georgia, Iceland, Japan and the Netherlands. In all cases, these countries are treating at least 7% of their infected population each year, and have opened treatment up to all those infected.

Published
18 June 2018
From
CDA Foundation
← First12345...149Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.